Home › Kanser sa Ulo at Leeg › Illinois › Chicago

Pag-aaral pangklinika para sa Kanser sa Ulo at Leeg sa Chicago, IL

Isang pag-aaral para sa Kanser sa Ulo at Leeg ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Nagre-recruitPhase 2/3

Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06788990

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 2

University of Illinois Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478

A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

Nagre-recruitPhase 2

The University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT07179315

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Nagre-recruitPhase 1/2

University of Chicago, Chicago

Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Nagre-recruitPhase 2

University of Chicago Comprehensive Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update May 12, 2026 · NCT05420948

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Nagre-recruitPhase 1

The University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT05526924

Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

Nagre-recruitPhase 2

The University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT07065630

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

Nagre-recruitPhase 1

University of Chicago Medicine Comprehensive Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 2, 2025 · NCT06912087

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Chicago

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

Nagre-recruitPhase 1/2

University of Illinois at Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2025 · NCT05838729

Pag-aaral para sa Kanser sa Ulo at Leeg sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.